The research progress on synchronous endometrial and ovarian carcinoma

Wenli Gan; Ce Bian

doi:10.3389/fonc.2023.1291602

The research progress on synchronous endometrial and ovarian carcinoma

Front Oncol. 2023 Dec 6:13:1291602. doi: 10.3389/fonc.2023.1291602. eCollection 2023.

Authors

Wenli Gan^{1

2}, Ce Bian¹

Affiliations

¹ Department of Gynecology and Obstetrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second Hospital, Sichuan University, Chengdu, Sichuan, China.
² Department of Gynecology and Obstetrics, Affiliated Hospital of Sichuan Nursing Vocational College (The Third People's Hospital of Sichuan Province), Chengdu, Sichuan, China.

Abstract

Synchronous endometrial and ovarian carcinoma (SEOC) is the most common combination of primary double cancer in the female reproductive system. The etiology and pathogenesis of SEOC remain unclear, and clinically, it is often misdiagnosed as metastatic cancer, affecting the formulation of treatment plans and prognosis for patients. This article provides a review of its epidemiology, pathological and clinical characteristics, risk factors, pathogenesis, diagnosis, treatment, and prognosis.

Keywords: endometrial neoplasia; ovarian neoplasia; prognosis; risk factor; synchronous.

Publication types

Review

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.